International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICRTET-4
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 5
September-October 2026
Indexing Partners
Quality Tools And Risk-Based Approaches In Analytical Method Validation And Bioequivalence Studies: A Comprehensive Review
| Author(s) | Ms. Karthika K.U., Ms. Shahanas Fathima V.V. |
|---|---|
| Country | India |
| Abstract | Analytical method validation and bioequivalence (BE) studies are important components of pharmaceuticaldevelopment because they provide evidence that analytical procedures are fit for their intended purpose and thatcomparative product performance can be assessed using reliable measurements. The contemporary regulatoryenvironment increasingly emphasizes scientific understanding, lifecycle management, quality risk management,and data integrity rather than validation as a one-time documentation exercise. This review examines practicalquality tools that can be integrated into analytical method development, validation, routine analysis,bioanalytical sample analysis, and BE study documentation. Particular attention is given to checklists, risk matrices, Failure Mode and Effects Analysis (FMEA), Ishikawa or fishbone analysis, root-cause analysis (RCA),control charts, trend analysis, analytical run review, system suitability verification, and data-integrity checks.The review also considers how risk-based controls can be connected with validation characteristics such asspecificity/selectivity, accuracy, precision, linearity, range, robustness, and detection or quantitation capability.For BE studies, quality controls are discussed across study planning, sample accountability, bioanalyticalanalysis, pharmacokinetic data handling, statistical evaluation, and final reporting. ICH Q2(R2), Q14 and Q9provide an important quality framework, while ICH M10, ICH M13A and current FDA recommendations provideadditional context for bioanalytical and BE activities. An integrated quality-tool framework can improveconsistency, traceability, early detection of failure, and continual improvement without replacing scientificjudgment or applicable regulatory requirements. |
| Keywords | Analytical method validation; Bioequivalence; Quality tools; Risk management; FMEA; ICH Q2(R2); ICH Q14; ICH Q9; ICH M10; Data integrity; System suitability; Pharmaceutical quality. |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 5, September-October 2026 |
| Published On | 2026-09-27 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals